WELCOME TO MEDINECT OPHTHO
Your medical innovations connected
with preclinical experts
We have a dedicated team who work closely with you to ensure you get the most out of your preclinical studies. We ensure your study meets the goals you set for each experiment through better study design using better research models.
WHO WE ARE
Drug development is challenging, especially in a new therapeutic area. Our focus is solely on retinal disease and we have experts to help you through difficult study designs and technical scientists who have been carrying out the procedures for years and you can trust. MediNect are a preclinical CRO that provides agile research solutions to advance your retinal disease therapy.
Our expertise is built on 25 years of academic research and development. With access to the UK’s second-largest preclinical ophthalmology suite, our facilities are state-of-the-art. Our team is dedicated to providing clients with deep discussions to answer their needs, and we pride ourselves on communication that suits you.
EARLY-STAGE PROOF OF CONCEPT SERVICE
Customised POC studies
Learn how we work closely with you to plan your early proof of concept work
LATE-STAGE PROOF OF CONCEPT SERVICE
Regulatory POC studies
We provide robust studies with clear well defined endpoints to ensure compliance for regulators
MECHANISM OF ACTION SERVICE
Investigatory research
We work alongside you bringing in subject experts to the table to help you understand your therapeutic further
ADME
PK/PD and distribution studies
Delivery via oral gavage, subcutaneous, intravitreal, sublingual, subconjunctival, sub-retinal, intraperitoneal
and intravenous.
As well as PK analysis - we offer distribution studies to determine the location of your therapeutic in the eye
sub-compartments